These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
450 related articles for article (PubMed ID: 31320709)
21. Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assay. Schwaederle M; Husain H; Fanta PT; Piccioni DE; Kesari S; Schwab RB; Banks KC; Lanman RB; Talasaz A; Parker BA; Kurzrock R Oncotarget; 2016 Mar; 7(9):9707-17. PubMed ID: 26848768 [TBL] [Abstract][Full Text] [Related]
22. Clinical correlates of blood-derived circulating tumor DNA in pancreatic cancer. Patel H; Okamura R; Fanta P; Patel C; Lanman RB; Raymond VM; Kato S; Kurzrock R J Hematol Oncol; 2019 Dec; 12(1):130. PubMed ID: 31801585 [TBL] [Abstract][Full Text] [Related]
23. Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Advanced Biliary Tract Cancer. Chen C; Wang T; Yang M; Song J; Huang M; Bai Y; Su H Pathol Oncol Res; 2021; 27():1609879. PubMed ID: 34720757 [No Abstract] [Full Text] [Related]
25. Circulating tumor DNA sequencing for colorectal cancers: A comparative analysis of colon cancer and rectal cancer data. Huang K; Qu H; Zhang X; Huang T; Sun X; He W; Li M; Lin L; Xu M; Chen S; Xia L Cancer Biomark; 2019; 26(3):313-322. PubMed ID: 31561327 [TBL] [Abstract][Full Text] [Related]
26. Modeling clonal structure over narrow time frames via circulating tumor DNA in metastatic breast cancer. Weber ZT; Collier KA; Tallman D; Forman J; Shukla S; Asad S; Rhoades J; Freeman S; Parsons HA; Williams NO; Barroso-Sousa R; Stover EH; Mahdi H; Cibulskis C; Lennon NJ; Ha G; Adalsteinsson VA; Tolaney SM; Stover DG Genome Med; 2021 May; 13(1):89. PubMed ID: 34016182 [TBL] [Abstract][Full Text] [Related]
27. Concordance of Genomic Alterations by Next-Generation Sequencing in Tumor Tissue versus Circulating Tumor DNA in Breast Cancer. Chae YK; Davis AA; Jain S; Santa-Maria C; Flaum L; Beaubier N; Platanias LC; Gradishar W; Giles FJ; Cristofanilli M Mol Cancer Ther; 2017 Jul; 16(7):1412-1420. PubMed ID: 28446639 [TBL] [Abstract][Full Text] [Related]
28. Molecular profiling of tumors of the brainstem by sequencing of CSF-derived circulating tumor DNA. Pan C; Diplas BH; Chen X; Wu Y; Xiao X; Jiang L; Geng Y; Xu C; Sun Y; Zhang P; Wu W; Wang Y; Wu Z; Zhang J; Jiao Y; Yan H; Zhang L Acta Neuropathol; 2019 Feb; 137(2):297-306. PubMed ID: 30460397 [TBL] [Abstract][Full Text] [Related]
34. Liquid biopsy: current technology and clinical applications. Nikanjam M; Kato S; Kurzrock R J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847 [TBL] [Abstract][Full Text] [Related]
35. Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types. Lebofsky R; Decraene C; Bernard V; Kamal M; Blin A; Leroy Q; Rio Frio T; Pierron G; Callens C; Bieche I; Saliou A; Madic J; Rouleau E; Bidard FC; Lantz O; Stern MH; Le Tourneau C; Pierga JY Mol Oncol; 2015 Apr; 9(4):783-90. PubMed ID: 25579085 [TBL] [Abstract][Full Text] [Related]
36. Analytical performance evaluation of a commercial next generation sequencing liquid biopsy platform using plasma ctDNA, reference standards, and synthetic serial dilution samples derived from normal plasma. Verma S; Moore MW; Ringler R; Ghosal A; Horvath K; Naef T; Anvari S; Cotter PD; Gunn S BMC Cancer; 2020 Oct; 20(1):945. PubMed ID: 33004033 [TBL] [Abstract][Full Text] [Related]
37. [Liquid biopsy in colorectal cancer : An overview of ctDNA analysis in tumour diagnostics]. Haupts A; Roth W; Hartmann N Pathologe; 2019 Dec; 40(Suppl 3):244-251. PubMed ID: 31797045 [TBL] [Abstract][Full Text] [Related]
38. PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study. Tzanikou E; Markou A; Politaki E; Koutsopoulos A; Psyrri A; Mavroudis D; Georgoulias V; Lianidou E Mol Oncol; 2019 Dec; 13(12):2515-2530. PubMed ID: 31254443 [TBL] [Abstract][Full Text] [Related]
39. Genomic mutation profiling using liquid biopsy in Korean patients with prostate cancer: Circulating tumor DNA mutation predicts the development of castration resistance. Yu J; Cho E; Choi J; Lim JE; Lee J; Kang M; Sung HH; Jeong BC; Seo SI; Jeon SS; Lee HM; Jeon HG Investig Clin Urol; 2021 Mar; 62(2):224-232. PubMed ID: 33660451 [TBL] [Abstract][Full Text] [Related]
40. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time? Asante DB; Calapre L; Ziman M; Meniawy TM; Gray ES Cancer Lett; 2020 Jan; 468():59-71. PubMed ID: 31610267 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]